Insights On Trial Design
-
Optimize Protocols For More Successful Trials
9/17/2024
Find out how you can harness the power of AI and world-class data to recommend endpoints and inclusion/exclusion criteria for streamlined protocol design that results in more positive trial outcomes.
-
DCTs For Older Adults: Mobile Research Trends And Recommendations
7/9/2024
Learn how DCTs can be tailored to suit the needs of older adults, potentially transforming geriatric clinical research and addressing the unique challenges faced by this growing population.
-
The True ROI Of Decentralized Clinical Trials
11/13/2025
Gain a greater understanding of how the right DCT solution, or combination of solutions, coupled with clear metrics and expert guidance on execution, can demonstrate tangible, quantitative ROI in clinical trials.
-
Meeting Eye Exam Needs At The Point Of Need
3/11/2025
Learn more about how mobile vision clinics supported the staff at trial sites as well as the patients through the COVID-19 pandemic and beyond.
-
The Scoop On The SCOPE Summit
2/19/2025
From industry partnerships to patient recruitment to proprietary data, SCOPE 2025 was packed with informational sessions.
-
How AI Is Reshaping Trial Design, Execution, And Disclosure
9/25/2025
AI has quietly embedded itself into the operational heart of clinical development, where it is accelerating decisions, reducing manual burden, and improving outcomes.
-
EHR-To-EDC Success In A Complex, Adaptive Platform Trial
4/17/2025
I-SPY 2, one of the longest-running adaptive platform trials in oncology, is revolutionizing breast cancer research through a dynamic, data-driven approach to evaluating novel therapies.
-
Why Community-Rooted Recruitment Is The Future Of Clinical Trials
4/10/2025
Despite clinical trial awareness campaigns and site expansions, trials continue to fall short in reaching the patients who need them most, resulting in a shift toward community-rooted recruitment.
-
Chronic Lymphocytic Leukemia: Global Clinical Trial Landscape (2024)
8/19/2024
CLL is slow-progressing leukemia primarily affecting older adults. Get the latest information on research, innovative therapies, and emerging clinical trials shaping CLL care by downloading this report.
-
Illuminating IHC: From Biomarker To Clinical Trial Assay
5/2/2025
Through this presentation, Immunohistochemistry (IHC) expert equip you with the knowledge needed to effectively utilize IHC in your research and clinical practice.